Arvaya Healthcare Expands with ₹60.65 Crore Acquisitions

Arvaya Healthcare Limited, formerly known as Bijoy Hans Limited, announced a significant strategic expansion through the acquisition of three healthcare entities for a total consideration of ₹60.65 crore. The company also reported its audited financial results for the year ended March 31, 2026.

Consolidated revenue from operations stood at ₹9.11 crore, with a consolidated profit for the period reported at ₹0.90 crore. The company's total assets were valued at ₹140.62 crore on a consolidated basis. In contrast, the standalone entity reported zero revenue from operations and a loss of ₹1.20 crore.

Reader Takeaway: Strategic acquisitions boost consolidated profit; standalone performance lags, litigation remains a watch point.

What just happened

Arvaya Healthcare Limited (formerly Bijoy Hans Limited) has successfully acquired a 100% equity stake in three separate healthcare companies: Health Secure Hospitals Private Limited for ₹29.40 crore, Arvaya Health and Wellness Private Limited for ₹18.75 crore, and Tec-Pool Solutions Private Limited for ₹12.50 crore. The total investment for these acquisitions amounts to ₹60.65 crore.

Why this matters

This move signifies a substantial shift in the company's business strategy, transforming it into a consolidated healthcare service provider through inorganic growth. The acquisitions are expected to drive future revenue and profitability, as reflected in the consolidated profit of ₹0.90 crore despite a standalone loss. The increase in authorized share capital to ₹200 crore signals readiness for further growth and potential funding needs.

The backstory

The company officially changed its name from Bijoy Hans Limited to Arvaya Healthcare Limited, effective May 11, 2026, to align with its new focus. The Board had approved an increase in authorized share capital from ₹60 crore to ₹200 crore on March 17, 2026. An unmodified opinion was given by the auditors on the financial results.

What changes now

Arvaya Healthcare is now positioned as a consolidated healthcare entity, with its performance increasingly dependent on the newly acquired subsidiaries. The expanded authorized capital provides flexibility for future capital raising to support its growth trajectory.

Risks to watch

The company is facing legal claims amounting to ₹3.72 crore from medical consultants. While management is confident of a favorable outcome, this litigation represents a potential contingent liability.

Peer comparison

Information on direct peers and their financial performance is not provided in the filing.

Context metrics (time-bound)

For the year ended March 31, 2026:

• Consolidated Revenue from operations: ₹9.11 crore
• Consolidated Profit: ₹0.90 crore
• Total Acquisitions: ₹60.65 crore
• Authorized Share Capital increased to: ₹200 crore

What to track next

Investors will be keen to monitor the integration of the acquired entities, the financial performance of the consolidated business, and the resolution of the ongoing legal claims.